Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and ...
The US Patent and Trademark Office told a group of specialized patent judges on Tuesday afternoon they could be expected to ...
Kristina Caggiano Kelly, David H. Holman and Lestin L. Kenton Jr. of Sterne, Kessler, Goldstein & Fox PLLC discuss a Federal ...
Seattle-based Parse Biosciences secured another major legal victory in its patent dispute with 10x Genomics Inc. (Nasdaq: TXG ...
This week we speak with Scott McKeown, who is a shareholder at Wolf Greenfield and one of the leading U.S. PTAB practitioners ...
On Jan. 29, 2025, the U.S. Patent and Trademark Office (USPTO) released statistics regarding the number and type of contested proceedings brought ...
On January 14, 2025, the United States Court of Appeals for the Federal Circuit (“CAFC”) issued a precedential opinion affirming a final ...
Atossa Therapeutics, Inc. expressed disappointment over the Patent Trial and Appeal Board's ruling deeming all challenged claims of U.S. Patent No. 11,572,334 unpatentable. While Atossa will not ...
The first day of IPWatchdog’s PTAB Masters 2025 wrapped up with a session in which three IP luminaries weighed in on the ...
SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, today ...
This week, hearings set before the Federal Court of Appeal and the Federal Court included matters relating to a Canadian ...
The Patent Trial and Appeal Board has jurisdiction to review patents’ validity even after their expiration, the Federal Circuit ruled in an opinion wiping out the last surviving claim from a camera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback